1
|
Harano N, Liang LW, Hasegawa K, Maurer MS, Tower-Rader A, Fifer MA, Reilly MP, Shimada YJ. Prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using proteomics profiling. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1727] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiac disorders and affects 1 in 200–500 individuals. HCM is known to be heterogeneous. Approximately 20–30% of patients with HCM develop atrial fibrillation (AF), which can lead to stroke and worsening of heart failure symptoms. As AF increases the risk of stroke by 8-fold, AF in HCM is a Class 1 indication for anticoagulation. Despite its high prevalence and clinical importance of early AF detection, there are no risk stratification tools available to predict new-onset AF in patients with HCM. Furthermore, it is still unknown which signaling pathways mediate AF in HCM. Proteomics profiling can determine concentrations of thousands of proteins and potentially reveal underlying molecular mechanisms of disease progression.
Purpose
To develop plasma proteomics-based model to predict new-onset AF in patients with HCM and to determine signaling pathways dysregulated in those who subsequently develop AF.
Methods
In this prospective, multi-center cohort study, we conducted plasma proteomics profiling of 5,032 proteins on 397 patients with HCM. We developed a proteomics-based random forest machine learning model to predict new-onset AF using samples from one institution (training set, n=278). We tested the predictive ability of the model using independent samples from the other institution (test set, n=119). We estimated the hazard ratio for new-onset AF using a Cox proportional hazards model comparing high- and low-risk groups as determined by the proteomics-based model. We also performed pathway analysis of proteins significantly (i.e., univariable P<0.05) associated with new-onset AF using a false discovery rate (FDR) threshold of 0.05.
Results
A total of 15 patients in the training set (5.4%) and 7 in the test set (5.9%) developed new-onset AF. Using the proteomics-based model developed in the training set, the area under the receiver-operating characteristic (ROC) curve to predict new-onset AF was 0.87 (95% confidence interval [CI] 0.77–0.98; Figure) in the test set. The sensitivity was 0.86 (95% CI 0.42–0.99) and the specificity was 0.77 (95% CI 0.68–0.84). In the test set, patients categorized as high-risk based on the proteomics model had a significantly higher rate of developing new-onset AF (hazard ratio 8.18; 95% CI 1.55–43.20; P=0.01). Pathway analysis revealed that the Ras-MAPK pathway was dysregulated in patients who subsequently developed AF (FDR=0.01; Table). Pathways involved in inflammation were also dysregulated.
Conclusions
This study serves as the first to demonstrate the ability of proteomics profiling to predict new-onset AF in patients with HCM, exhibiting dysregulation of both novel (e.g., Ras-MAPK) and known pathways in patients who subsequently experience AF. These results not only exhibit the utility of proteomics profiling for clinical risk stratification but also suggest mechanisms underlying the development of AF in HCM.
Funding Acknowledgement
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): NIH/NHLBI
Collapse
Affiliation(s)
- N Harano
- Columbia University , New York , United States of America
| | - L W Liang
- Columbia University Medical Center , New York , United States of America
| | - K Hasegawa
- Massachusetts General Hospital - Harvard Medical School , Boston , United States of America
| | - M S Maurer
- Columbia University Medical Center , New York , United States of America
| | - A Tower-Rader
- Massachusetts General Hospital - Harvard Medical School , Boston , United States of America
| | - M A Fifer
- Massachusetts General Hospital - Harvard Medical School , Boston , United States of America
| | - M P Reilly
- Columbia University Medical Center , New York , United States of America
| | - Y J Shimada
- Columbia University Medical Center , New York , United States of America
| |
Collapse
|
2
|
Tanaka T, Shiiba S, Yoshino N, Harano N, Sago T, Kito S, Matsumoto-Takeda S, Wakasugi-Sato N, Oda M, Joujima T, Miyamura Y, Imamura Y, Morimoto Y. Predicting the therapeutic effect of carbamazepine in trigeminal neuralgia by analysis of neurovascular compression utilizing magnetic resonance cisternography. Int J Oral Maxillofac Surg 2019; 48:480-487. [DOI: 10.1016/j.ijom.2018.09.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2018] [Revised: 09/21/2018] [Accepted: 09/27/2018] [Indexed: 11/24/2022]
|
3
|
Nodai T, Hitomi S, Ono K, Masaki C, Harano N, Morii A, Sago-Ito M, Ujihara I, Hibino T, Terawaki K, Omiya Y, Hosokawa R, Inenaga K. Endothelin-1 Elicits TRP-Mediated Pain in an Acid-Induced Oral Ulcer Model. J Dent Res 2018. [PMID: 29518348 DOI: 10.1177/0022034518762381] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Oral ulcer is the most common oral disease and leads to pain during meals and speaking, reducing the quality of life of patients. Recent evidence using animal models suggests that oral ulcers induce cyclooxygenase-dependent spontaneous pain and cyclooxygenase-independent mechanical allodynia. Endothelin-1 is upregulated in oral mucosal inflammation, although it has not been shown to induce pain in oral ulcers. In the present study, we investigated the involvement of endothelin-1 signaling with oral ulcer-induced pain using our proprietary assay system in conscious rats. Endothelin-1 was significantly upregulated in oral ulcers experimentally induced by topical acetic acid treatment, while endothelin-1 production was suppressed by antibacterial pretreatment. Spontaneous nociceptive behavior in oral ulcer model rats was inhibited by swab applications of BQ-788 (ETB receptor antagonist), ONO-8711 (prostanoid receptor EP1 antagonist), and HC-030031 (TRPA1 antagonist). Prostaglandin E2 production in the ulcers was suppressed by BQ-788. Mechanical allodynia in the model was inhibited not only by BQ-788 and HC-030031 but also by BQ-123 (ETA receptor antagonist), SB-366791 (TRPV1 antagonist), and RN-1734 (TRPV4 antagonist). In naive rats, submucosal injection of endothelin-1 caused mechanical allodynia that was sensitive to HC-030031 and SB-366791 but not to RN-1734. These results suggest that endothelin-1 production following oral bacterial invasion via ulcerative regions elicits TRPA1-mediated spontaneous pain. This pain likely occurs through an indirect route that involves ETB receptor-accelerated prostanoid production. Endothelin-1 elicits directly TRPA1- and TRPV1-mediated mechanical allodynia via both ETA and ETB receptors on nociceptive fibers. The TRPV4-mediated allodynia component seems to be independent of endothelin signaling. These findings highlight the potential of endothelin signaling blockers as effective analgesic approaches for oral ulcer patients.
Collapse
Affiliation(s)
- T Nodai
- 1 Division of Physiology, Kyushu Dental University, Fukuoka, Japan.,2 Division of Oral Reconstruction and Rehabilitation, Kyushu Dental University, Fukuoka, Japan
| | - S Hitomi
- 1 Division of Physiology, Kyushu Dental University, Fukuoka, Japan
| | - K Ono
- 1 Division of Physiology, Kyushu Dental University, Fukuoka, Japan
| | - C Masaki
- 2 Division of Oral Reconstruction and Rehabilitation, Kyushu Dental University, Fukuoka, Japan
| | - N Harano
- 3 Division of Dental Anesthesiology, Kyushu Dental University, Fukuoka, Japan
| | - A Morii
- 1 Division of Physiology, Kyushu Dental University, Fukuoka, Japan.,4 Division of Orofacial Functions and Orthodontics, Kyushu Dental University, Fukuoka, Japan
| | - M Sago-Ito
- 4 Division of Orofacial Functions and Orthodontics, Kyushu Dental University, Fukuoka, Japan
| | - I Ujihara
- 1 Division of Physiology, Kyushu Dental University, Fukuoka, Japan
| | - T Hibino
- 5 Tsumura Research Laboratories, Kampo Scientific Strategies Division, Tsumura & Co., Ibaraki, Japan
| | - K Terawaki
- 5 Tsumura Research Laboratories, Kampo Scientific Strategies Division, Tsumura & Co., Ibaraki, Japan
| | - Y Omiya
- 5 Tsumura Research Laboratories, Kampo Scientific Strategies Division, Tsumura & Co., Ibaraki, Japan
| | - R Hosokawa
- 2 Division of Oral Reconstruction and Rehabilitation, Kyushu Dental University, Fukuoka, Japan
| | - K Inenaga
- 1 Division of Physiology, Kyushu Dental University, Fukuoka, Japan
| |
Collapse
|
4
|
Yamamoto T, Ono K, Hitomi S, Harano N, Sago T, Yoshida M, Nunomaki M, Shiiba S, Watanabe S, Nakanishi O, Inenaga K. Endothelin receptor-mediated responses in trigeminal ganglion neurons. J Dent Res 2013; 92:335-9. [PMID: 23396520 DOI: 10.1177/0022034513478428] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Recent evidence implicates endothelin in nociception, but it is unclear how endothelin activates trigeminal ganglion (TRG) neurons. In the present study, we investigated the expression of the endothelin receptors ETA and ETB and endothelin-induced responses in rat TRG neurons. Double-immunofluorescence studies demonstrated that ETA and ETB were expressed in TRG neurons and that 26% of ETA- or ETB-expressing neurons expressed both receptors. During whole-cell patch-clamp recording, endothelin-1 enhanced an induced current in response to capsaicin, a TRPV1 agonist, in approximately 20% of dissociated neurons. The enhancement was blocked by the PKC inhibitor chelerythrine and by the ETA antagonist BQ-123, but not by the ETB antagonist BQ-788. Ca(2+)-imaging showed that endothelin-1 increased the intracellular Ca(2+) concentration in more than 20% of the dissociated neurons. Importantly, unlike the effect of endothelin-1 on capsaicin-induced current, the Ca(2+) response was largely suppressed by BQ-788 but not by BQ-123. These results suggest that ETA-mediated TRPV1 hyperactivation via PKC activation and ETB-mediated Ca(2+) mobilization occurs in different subsets of TRG neurons. These endothelin-induced responses may contribute to the induction of orofacial pain. The ETB-mediated function in TRG neurons is a special feature in the trigeminal system because of no ETB expression in dorsal root ganglion neurons.
Collapse
Affiliation(s)
- T Yamamoto
- Division of Physiology, Kokurakitaku, Kitakyushu, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Abstract
Rat models of orofacial cancer exhibit both allodynia and hyperalgesia; however, it is unclear whether cancer-induced pain is secondary to cancer-induced inflammation. To address this question, we compared the effects of an anti-inflammatory drug, indomethacin, on pain and neurochemical changes in the medullary dorsal horn in orofacial inflammation and cancer models. Daily peripheral administration of indomethacin largely suppressed mechanical allodynia and thermal hyperalgesia in the inflammation model. The same procedure suppressed allodynia and hyperalgesia in the cancer model, but the suppression was weak when compared with that in the inflammation model. In the medullary dorsal horn, calcitonin gene-related peptide and substance P levels were significantly increased in the inflammation model, but did not change in the cancer model. These results suggest that pain in the orofacial cancer model is not significantly mediated by cancer-induced peripheral inflammation, although it may have some involvement.
Collapse
Affiliation(s)
- N. Harano
- Department of Control of Physical Functions, Kyushu Dental College, 2-6-1 Manazuru, Kokurakitaku, Kitakyushu, Fukuoka, 803-8580, Japan
| | - K. Ono
- Department of Biosciences, Kyushu Dental College, 2-6-1 Manazuru, Kokurakitaku, Kitakyushu, Fukuoka, 803-8580, Japan
| | - K. Hidaka
- Department of Control of Physical Functions, Kyushu Dental College, 2-6-1 Manazuru, Kokurakitaku, Kitakyushu, Fukuoka, 803-8580, Japan
- Department of Biosciences, Kyushu Dental College, 2-6-1 Manazuru, Kokurakitaku, Kitakyushu, Fukuoka, 803-8580, Japan
| | - A. Kai
- Department of Control of Physical Functions, Kyushu Dental College, 2-6-1 Manazuru, Kokurakitaku, Kitakyushu, Fukuoka, 803-8580, Japan
| | - O. Nakanishi
- Department of Control of Physical Functions, Kyushu Dental College, 2-6-1 Manazuru, Kokurakitaku, Kitakyushu, Fukuoka, 803-8580, Japan
| | - K. Inenaga
- Department of Biosciences, Kyushu Dental College, 2-6-1 Manazuru, Kokurakitaku, Kitakyushu, Fukuoka, 803-8580, Japan
| |
Collapse
|
6
|
|